1. Saarimäki M Pharmacokinetics and absorption of foscarnet after intravenous and oral administration to patients with human immunodeficiency virus;Jan;Clin. Pharmacol. Ther.,1988
2. Pharmacology and clinical use of foscarnet;Gérard;Int. J. Antimicrob. Agents,1995
3. Antiviral drugs in current clinical use;De Clercq;J. Clin. Virol.,2004
4. Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management,ANTIMICROB. AGENTS;Guy,2011
5. Iramain, Silvia A. Brandán, Structural and vibrational study on the acid, hexa-hydrated and anhydrous trisodic salts of antiviral drug Foscarnet, drug design;Maximiliano;J. Intellect. Prop.,2018